DiscGenics Raises $50 Million in Series C Funding
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SALT LAKE CITY, Aug. 26, 2020 /PRNewswire-AsiaNet/ -- DiscGenics, Inc. ( https://www.discgenics.com/ ), a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced...
Authors: LATEST ASIANET NEWS RELEASES